Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Lehmann

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|March 25, 2006
Ecallantide (Dyax/Genzyme)Andreas Lehmann
Expert Opinion on Biological Therapy|July 11, 2008
Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgeryAndreas Lehmann
American Journal of Human Biology : the Official Journal of the Human Biology Council|March 31, 2016
What does the mean menarcheal age mean?-An analysis of temporal pattern in variability in a historical swiss population from the 19th and 20th centuriesAndreas Lehmann, Christiane Scheffler
Journal of Cardiothoracic and Vascular Anesthesia|March 5, 2005
New pharmacologic approaches for the perioperative treatment of ischemic cardiogenic shockAndreas Lehmann, Joachim Boldt
Biotechnology Progress|January 17, 2008
Computational design of four-helix bundle proteins that bind nonbiological cofactorsAndreas Lehmann, Jeffery G Saven
The Journal of Pharmacy and Pharmacology|July 27, 2018
Differences in drug quality between South Africa and GermanyAndreas Lehmann, Martin Hofsäss, Jennifer Dressman
Future Cardiology|October 7, 2009
Cardioprotective anesthesia in patients undergoing coronary surgery: fact or fiction?Andreas Lehmann, Joachim Boldt, Frank Isgro
Obstetrical & Gynecological Survey|April 13, 2012
Psychosocial pressure and menarche: a review of historic evidence for social amenorrheaMichael Hermanussen, Andreas Lehmann, Christiane Scheffler
Current Opinion in Critical Care|September 26, 2003
The role of Ca++-sensitizers for the treatment of heart failureAndreas Lehmann, Joachim Boldt, Jürgen Kirchner
Anthropologischer Anzeiger; Bericht Uber Die Biologisch-Anthropologische Literatur|October 20, 2010
The variation in age at menarche: an indicator of historic developmental tempoAndreas Lehmann, Christiane Scheffler, Michael Hermanussen
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Current Opinion in Investigational Drugs (London, England : 2000)|March 25, 2006
Ecallantide (Dyax/Genzyme)Andreas Lehmann
Expert Opinion on Biological Therapy|July 11, 2008
Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgeryAndreas Lehmann
American Journal of Human Biology : the Official Journal of the Human Biology Council|March 31, 2016
What does the mean menarcheal age mean?-An analysis of temporal pattern in variability in a historical swiss population from the 19th and 20th centuriesAndreas Lehmann, Christiane Scheffler
Journal of Cardiothoracic and Vascular Anesthesia|March 5, 2005
New pharmacologic approaches for the perioperative treatment of ischemic cardiogenic shockAndreas Lehmann, Joachim Boldt
Biotechnology Progress|January 17, 2008
Computational design of four-helix bundle proteins that bind nonbiological cofactorsAndreas Lehmann, Jeffery G Saven
The Journal of Pharmacy and Pharmacology|July 27, 2018
Differences in drug quality between South Africa and GermanyAndreas Lehmann, Martin Hofsäss, Jennifer Dressman
Future Cardiology|October 7, 2009
Cardioprotective anesthesia in patients undergoing coronary surgery: fact or fiction?Andreas Lehmann, Joachim Boldt, Frank Isgro
Obstetrical & Gynecological Survey|April 13, 2012
Psychosocial pressure and menarche: a review of historic evidence for social amenorrheaMichael Hermanussen, Andreas Lehmann, Christiane Scheffler
Current Opinion in Critical Care|September 26, 2003
The role of Ca++-sensitizers for the treatment of heart failureAndreas Lehmann, Joachim Boldt, Jürgen Kirchner
Anthropologischer Anzeiger; Bericht Uber Die Biologisch-Anthropologische Literatur|October 20, 2010
The variation in age at menarche: an indicator of historic developmental tempoAndreas Lehmann, Christiane Scheffler, Michael Hermanussen
Pageof 9